AU6252699A - Composition and method for treating allergic diseases - Google Patents

Composition and method for treating allergic diseases

Info

Publication number
AU6252699A
AU6252699A AU62526/99A AU6252699A AU6252699A AU 6252699 A AU6252699 A AU 6252699A AU 62526/99 A AU62526/99 A AU 62526/99A AU 6252699 A AU6252699 A AU 6252699A AU 6252699 A AU6252699 A AU 6252699A
Authority
AU
Australia
Prior art keywords
composition
allergic diseases
treating allergic
treating
diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU62526/99A
Inventor
Robert G Aslanian
John J. Piwinski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme Corp
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of AU6252699A publication Critical patent/AU6252699A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU62526/99A 1998-10-09 1999-10-06 Composition and method for treating allergic diseases Abandoned AU6252699A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16960898A 1998-10-09 1998-10-09
US09169608 1998-10-09
PCT/US1999/021437 WO2000021512A2 (en) 1998-10-09 1999-10-06 Composition and method for treating allergic diseases

Publications (1)

Publication Number Publication Date
AU6252699A true AU6252699A (en) 2000-05-01

Family

ID=22616405

Family Applications (1)

Application Number Title Priority Date Filing Date
AU62526/99A Abandoned AU6252699A (en) 1998-10-09 1999-10-06 Composition and method for treating allergic diseases

Country Status (10)

Country Link
EP (1) EP1117405A2 (en)
JP (1) JP2002527381A (en)
CN (1) CN1329490A (en)
AR (1) AR020740A1 (en)
AU (1) AU6252699A (en)
CA (1) CA2346227A1 (en)
CO (1) CO5140078A1 (en)
MY (1) MY130725A (en)
PE (1) PE20001097A1 (en)
WO (1) WO2000021512A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20020324A1 (en) * 2000-10-06 2002-06-18 Boehringer Ingelheim Int NEW PHARMACEUTICAL COMPOSITIONS CONTAINING EPINASTIN AND PSEUDOEPHEDRINE
PE20020507A1 (en) * 2000-10-17 2002-06-25 Schering Corp NON-IMIDAZOLE COMPOUNDS AS ANTAGONISTS OF THE HISTAMINE H3 RECEPTOR
WO2004069338A1 (en) * 2003-01-31 2004-08-19 Schering Corporation Use of combinations of h1 and h3 histamine receptor antagonists for the preparation of a medicament for the treatment of allergic skin and allergic ocular conditions
WO2008090114A1 (en) 2007-01-24 2008-07-31 Glaxo Group Limited Pharmaceutical compositions comprising 2-methoxy-5- (5-trifluoromethyl-tetrazol-i-yl-benzyl) - (2s-phenyl-piperidin-3s-yl-)
WO2009142772A2 (en) 2008-05-23 2009-11-26 Mastcell Pharmaceuticals, Inc. Methods and treatment for allergies and inflammation associated with gastrointestinal diseases
DE102012102417A1 (en) 2012-03-21 2013-09-26 Balluff Gmbh identification system
EP3520803A1 (en) * 2018-01-31 2019-08-07 Zarodex Therapeutics Limited Novel uses
CN116496205A (en) * 2022-05-06 2023-07-28 成都施贝康生物医药科技有限公司 Cardustatin salt and application thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9310066D0 (en) * 1993-05-17 1993-06-30 Zeneca Ltd Alkyl substituted heterocycles
EP0777666B1 (en) * 1994-08-25 1999-03-03 Merrell Pharmaceuticals Inc. Substituted piperidines useful for the treatment of allergic diseases
US5688960A (en) * 1995-05-02 1997-11-18 Schering Corporation Substituted oximes, hydrazones and olefins useful as neurokinin antagonists
AR008293A1 (en) * 1996-08-16 1999-12-29 Schering Corp COMPOSITION THAT INCLUDES AN ANTIHISTAMINIC AMOUNT FOR THE TREATMENT OF ALLERGIC RESPONSES OF THE SUPERIOR RESPIRATORY TRACT

Also Published As

Publication number Publication date
CO5140078A1 (en) 2002-03-22
CA2346227A1 (en) 2000-04-20
MY130725A (en) 2007-07-31
WO2000021512A3 (en) 2000-07-06
JP2002527381A (en) 2002-08-27
CN1329490A (en) 2002-01-02
WO2000021512A2 (en) 2000-04-20
EP1117405A2 (en) 2001-07-25
PE20001097A1 (en) 2000-10-31
AR020740A1 (en) 2002-05-29

Similar Documents

Publication Publication Date Title
AU2593900A (en) Composition and method for treating glaucoma
AU6872498A (en) Method and composition for skin treatment
AU1296099A (en) Methods and compositions for treating dermatoses
AU3512295A (en) Composition and method for treating hair
AU2002219945A1 (en) Composition and method for treating snoring
AU5439996A (en) Compositions and methods for treating pain
AU8693098A (en) Compositions and methods for treating diabetes
AU2327599A (en) Compositions and methods for treating autoimmune diseases
AU4868599A (en) Composition for and method of treating neurological disorders
AU7748000A (en) Method and composition for the treatment of dermatologic diseases
AU5336499A (en) Composition and method of treating disease with extract of (musaceas)
EP1143952A3 (en) Method and composition for treating and preventing tuberculosis
AU3401199A (en) Method and composition for treating psoriasis
AU3768795A (en) Method and compositions for hair treatment
AU3204899A (en) Hair treatment composition and method
AU6252699A (en) Composition and method for treating allergic diseases
AU3127795A (en) Composition and treatment for baldness
AU4515001A (en) Compositions and methods for locally treating inflammatory diseases
AU6391199A (en) Composition and method for treating allergic diseases
AU2420101A (en) Method and composition for the treatment of pain
AU2001238288A1 (en) Method and compositions for treating fibrotic diseases
AU2393500A (en) Method for preventing and treating the degeneration of neurons
AU7604100A (en) Composition and method for treating burns
AU2461999A (en) Pharmaceutical composition and method for treating di-hydroxytestosterone dependent conditions
AU8049098A (en) Composition and methods for the treatment of inflammatory diseases

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase